Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia.
Our aim was to evaluate bone status in boys with haemophilia using dual energy X-ray absorptiometry (DXA) and quantitative ultraSonography (QUS), and in addition, to compare these two methods with the use of biochemical markers of bone turnover. Twenty-six boys with a mean decimal age of 12.08 ± 4.44 years were included in the study which included a DXA scan at lumbar spine and radial, as well as tibial QUS. Serum levels of soluble receptor activator of nuclear factor κB ligand (sRANK-L), osteoprotegerin (OPG) and osteocalcin (OC) were measured and joint evaluation was performed using the Hemophilia Joint Health Score (HJHS). With regard to the study results, only 2 of 26 patients (7.7%) had bone mineral density (BMD) Z-scores < -2, and 4 patients (15.4%) had BMD Z-scores between -1 and -2. Only one patient had radial and other two had tibial QUS Z-scores < -2. No agreement was recorded between QUS and DXA in identifying patients at risk for osteoporosis (k = 0.275, P = 0.063). Haemophiliacs had significantly higher serum levels of sRANK-L (21.04 ± 4.78 vs. 18.58 ± 2.28 ng mL(-1), P = 0.038) and of OC (5.35 ± 2.29 vs. 3.09 ± 0.61 ng mL(-1), P = 0.002) and significantly decreased levels of OPG (15.78 ± 2.53 vs. 23.79 ± 4.39 pg mL(-1), P < 0.001) compared with controls. QUS Z-scores at tibia significantly correlated with HJH Scores (r = -0.450, P = 0.040), whereas lumbar BMD Z-scores significantly correlated with body mass index Z-scores (r = 0.500, P = 0.009). More studies are warranted to identify the most accurate densitometric method for assessing bone status in haemophiliacs.
Christoforidis
A
A
1st Paediatric Department, Aristotle University, Thessaloniki, Greece. christoforidis@doctors.org.uk
Economou
M
M
Papadopoulou
E
E
Kazantzidou
E
E
Farmaki
E
E
Tzimouli
V
V
Tsatra
I
I
Gompakis
N
N
Athanassiou-Metaxa
M
M
D015502:Absorptiometry, Photon; D000293:Adolescent; D015415:Biomarkers / Q000378:metabolism; D015519:Bone Density / Q000502:physiology*; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging; D002648:Child; D002675:Child, Preschool; D006467:Hemophilia A / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging; D008297:Male; D016328:NF-kappa B / Q000097:blood; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis / Q000097:blood* / Q000503:physiopathology*; D053244:Osteoprotegerin / Q000097:blood; D053245:RANK Ligand / Q000097:blood; D011884:Radius / Q000000981:diagnostic imaging; D012016:Reference Values; D012307:Risk Factors; D013977:Tibia / Q000000981:diagnostic imaging; D014463:Ultrasonography
D015415:Biomarkers; D016328:NF-kappa B; D053244:Osteoprotegerin; D053245:RANK Ligand; D015675:Osteocalcin